Showing results (31-40 of 102) with videos related to
Sort By:
Pageof 11
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|June 13, 2020
[Phylogenetic structure of Abies georgei var. smithii community at different spatial scales in Sygera Mountains of Tibet, China]Zi-Ling Yang, Min-Xia Tian, Wu-Yang Yu, et al.Frontiers in Oncology|March 15, 2021
Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular CarcinomaJie Mei, Yu-Hao Tang, Wei Wei, et al.Medicine|February 20, 2021
Features of the gut microbiota in ulcerative colitis patients with depression: A pilot studyDe-Liang Chen, Yan-Cheng Dai, Lie Zheng, et al.Scientific Reports|January 9, 2015
The effectiveness of RECIST on survival in patients with NSCLC receiving chemotherapy with or without target agents as first-line treatmentTing Zhou, Lie Zheng, Zhihuang Hu, et al.Frontiers in Oncology|August 1, 2022
Radiomic Signatures for Predicting EGFR Mutation Status in Lung Cancer Brain MetastasesLie Zheng, Hui Xie, Xiao Luo, et al.Future Oncology (London, England)|February 3, 2022
Efficacy of adjuvant EGFR inhibitors and impact of clinical factors in resected EGFR-mutated non-small-cell lung cancer: a meta-analysisMeichen Li, Xue Hou, Suxia Lin, et al.Inflammation|April 30, 2014
High serum trypsin levels and the -409 T/T genotype of PRSS1 gene are susceptible to neonatal sepsisQingquan Chen, Heng Xue, Min Chen, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 17, 2002
[Comparison of enhanced thin CT sections with pathologic findings in pulmonary carcinoma, inflammatory, pseudo-tumor and pulmonary tuberculoma]Zhenfeng Zhang, Chenghui Zhang, Peihong Wu, et al.Frontiers in Medicine|October 7, 2022
Body mass index, as a novel predictor of hepatocellular carcinoma patients treated with Anti-PD-1 immunotherapyJierong Chen, Lianghe Lu, Chunhua Qu, et al.Plos One|January 30, 2016
Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated RadiotherapyJun-Fang Liao, Li Ma, Xiao-Jing Du, et al.Pageof 11